Clinical Medicine Reviews in Therapeutics

4,282 Journal Article Views | Journal Analytics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper

Publication Date: 16 Mar 2010

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2010:2

doi: 10.4137/CMRT.S1600


Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.



BibTex citation   (BIBDESK, LATEX)

What Your Colleagues Say About Libertas Academica
This is the second time I have submitted a paper to Palliative Care: Research and Treatment for possible publication.  In both instances, my experience with Libertas Academica was very good from submission to acceptance.  The peer reviewers' comments were insightful, very constructive, and extremely helpful.  The author interface was user-friendly.  The publishing process was fast and convenient. I highly recommend this journal.
Dr Liza Manalo (Palliative Care Unit, Cancer Center, The Medical City, Pasig City, Philippines)
More Testimonials

Quick Links

New article and journal news notification services